Multiplex CRISPR-Cas9 Gene-Editing Can Deliver Potato Cultivars with Reduced Browning and Acrylamide

被引:20
|
作者
Ly, Diem Nguyen Phuoc [1 ,2 ]
Iqbal, Sadia [1 ,2 ]
Fosu-Nyarko, John [1 ,2 ]
Milroy, Stephen [1 ,3 ]
Jones, Michael G. K. [1 ,2 ,3 ]
机构
[1] Murdoch Univ, Coll Environm & Life Sci, Sch Agr Sci, Crop Biotechnol Res Grp, Perth, WA 6150, Australia
[2] Murdoch Univ, Food Futures Inst, State Agr Biotechnol Ctr, Ctr Crop & Food Innovat, Perth, WA 6150, Australia
[3] Murdoch Univ, Potato Res Western Australia, Perth, WA 6150, Australia
来源
PLANTS-BASEL | 2023年 / 12卷 / 02期
关键词
CRISPR-Cas9; gene-editing; potato; reducing sugars; acrylamide formation; vacuolar invertase; asparagine synthetase; potato crisps; Atlantic; Desiree; VACUOLAR INVERTASE; RESISTANCE; SUCROSE; RNA;
D O I
10.3390/plants12020379
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Storing potato tubers at cold temperatures, either for transport or continuity of supply, is associated with the conversion of sucrose to reducing sugars. When cold-stored cut tubers are processed at high temperatures, with endogenous asparagine, acrylamide is formed. Acrylamide is classified as a carcinogen. Potato processors prefer cultivars which accumulate fewer reducing sugars and thus less acrylamide on processing, and suitable processing cultivars may not be available. We used CRISPR-Cas9 to disrupt the genes encoding vacuolar invertase (VInv) and asparagine synthetase 1 (AS1) of cultivars Atlantic and Desiree to reduce the accumulation of reducing sugars and the production of asparagine after cold storage. Three of the four guide RNAs employed induced mutation frequencies of 17-98%, which resulted in deletions, insertions and substitutions at the targeted gene sites. Eight of ten edited events had mutations in at least one allele of both genes; for two, only the VInv was edited. No wild-type allele was detected in both genes of events DSpco7, DSpFN4 and DSpco12, suggesting full allelic mutations. Tubers of two Atlantic and two Desiree events had reduced fructose and glucose concentrations after cold storage. Crisps from these and four other Desiree events were lighter in colour and included those with 85% less acrylamide. These results demonstrate that multiplex CRISPR-Cas9 technology can generate improved potato cultivars for healthier processed potato products.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
    Maggio, Ignazio
    Zittersteijn, Hidde A.
    Wang, Qian
    Liu, Jin
    Janssen, Josephine M.
    Ojeda, Ivan Toral
    van der Maarel, Silvere M.
    Lankester, Arjan C.
    Hoeben, Rob C.
    Goncalves, Manuel A. F. V.
    GENE THERAPY, 2020, 27 (05) : 209 - 225
  • [22] PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts
    Arnt Sant'Ana, Rodrigo Ribeiro
    Caprestano, Clarissa Alves
    Nodari, Rubens Onofre
    Agapito-Tenfen, Sarah Zanon
    GENES, 2020, 11 (09) : 1 - 14
  • [23] Potato genome editing directed by CRISPR-Cas9 ribonucleoprotein complexes
    Khromov, Andrey V.
    Makhotenko, Antonida V.
    Kalinina, Nataila O.
    Snigir, Ekaterina A.
    Makarova, Svetlana S.
    Makarov, Valentin V.
    Suprunova, Tatyana P.
    Taliansky, Michael E.
    JOURNAL OF BIOTECHNOLOGY, 2018, 280 : S87 - S87
  • [24] Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery
    Andersson, Mariette
    Turesson, Helle
    Olsson, Niklas
    Falt, Ann-Sofie
    Ohlsson, Pia
    Gonzalez, Matias N.
    Samuelsson, Mathias
    Hofvander, Per
    PHYSIOLOGIA PLANTARUM, 2018, 164 (04) : 378 - 384
  • [25] CRISPR/Cas9 gene-editing strategies in cardiovascular cells
    Vermersch, Eva
    Jouve, Charlene
    Hulot, Jean-Sebastien
    CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 894 - 907
  • [26] Application of CRISPR-Cas9 gene editing to treat HBV
    Yan, Kun
    Feng, Jiangpeng
    Xiong, Yong
    Chen, Yu
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3142 - 3150
  • [27] CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
    Rim, John Hoon
    Gopalappa, Ramu
    Gee, Heon Yung
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1722 - 1722
  • [28] CRISPR-cas9 gene editing in undergraduate laboratory experience
    Kee, H. Lynn
    Pieczynski, Jay
    FASEB JOURNAL, 2019, 33
  • [29] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
    Castillo, Andres
    COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180
  • [30] Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle
    Malech, Harry L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 286 - 287